Autopsy report · NCT02395692
Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma
Cause of deathOther
“Pre-specified response criteria not met to proceed to next stage of study.”
Life of this trial
- Registered 9 months before it started.
- Ran for about 1 year 2 months before it stopped.
- 20 participants enrolled.
- Results were posted on the registry 2 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- National Cancer Institute (NCI)
- Sponsor type
- US National Institutes of Health
- Conditions
- Adult Brain Glioblastoma
- Interventions
- Treatment; Methoxyamine; Temozolomide
- Participants
- 20
- Sites
- 12
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.